IP Library Granted Patent US 11,241,385
Granted Patent B2
US 11,241,385 · App. 16/139,363 · Granted Feb 8, 2022

Topical composition and method for treating and preventing atopic dermatitis and infections related to bacteria biofilm

Inventors: Sandra Noe (La Roquette, FR); Manon Rossano (Val de Reuil, FR)
Assignee: Johnson & Johnson Consumer Inc.
A61K9/1075A61K9/0014A61K47/02A61K47/10A61K47/186A61K47/22A61K47/38A61K47/44A61P17/04A61P31/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,241,385
App. No.
16/139,363
Granted
Feb 8, 2022
Kind
B2
Abstract

A nanoemulsion containing a quaternary ammonium salt with at least a twenty carbon chain is effective to prevent the growth of biofilms.

Claims (13)

1. A topical composition comprising an oil in water nanoemulsion wherein said nanoemulsion comprises

behentrimonium chloride, wherein said behentrimonium chloride is present in an amount from about 2% to about 5% by weight of the composition,

glycerin, wherein said glycerin is present in an amount from about 5% to about 15% by weight of the composition;

a water phase; and

cetyl alcohol, wherein said cetyl alcohol is present in an amount 0.5% to about 5% by weight of the composition,

wherein said nanoemulsion comprise droplets having a Sauter diameter D[3;2] between about 52 nm to about 60 nm.

2. The topical composition according to claim 1 , wherein said composition is free of additional surfactants.

3. The topical composition according to claim 1 , wherein said nanoemulsion comprises droplets having a Sauter diameter D[3;2] of about 52 nm.

4. The topical composition according to claim 1 , wherein the topical composition comprises about 5% to about 15% by weight of water based on total weight of the topical composition.

5. The topical composition according to claim 1 , comprising about 50% to about 90% by weight of water based on total weight of the topical composition.

6. The topical composition according to claim 1 , wherein said composition is free of a preservative.

7. A method of killing or inhibiting the growth of bacteria in a biofilm comprising exposing a biofilm to the nanoemulsion according to claim 1 .

8. The method of claim 7 , wherein the bacteria in the biofilm is Staphylococcus aureus.

Assignments (8)
CHANGE OF NAME Recorded Oct 28, 2024
From: JOHNSON & JOHNSON CONSUMER INC.
To: KENVUE BRANDS LLC
Reel/Frame 069267/0143 →
CERTIFICATE OF CONVERSION Recorded Jan 19, 2023
From: JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 062438/0521 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2023
From: JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 062438/0372 →
MERGER Recorded Jan 27, 2022
From: JOHNSON & JOHNSON CONSUMER INC.
To: CHENANGO ZERO LLC
Reel/Frame 059618/0521 →
MERGER Recorded Jan 27, 2022
From: CHENANGO ZERO LLC
To: CHENANGO TWO LLC
Reel/Frame 058888/0133 →
MERGER AND CHANGE OF NAME Recorded Jan 27, 2022
From: CHENANGO TWO LLC; CURRAHEE HOLDING COMPANY INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 058888/0210 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2018
From: NOE, SANDRA; ROSSANO, MANON
To: JOHNSON & JOHNSON SANTÉ BEAUTÉ FRANCE
Reel/Frame 047526/0887 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2018
From: JOHNSON & JOHNSON SANTÉ BEAUTÉ FRANCE
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 047527/0359 →
Continuity (2)
Provisional Application 62563114 · Sep 26, 2017
Related Publication 20190091148A1 · Mar 28, 2019